Investing

Top Analyst Upgrades and Downgrades: Atmos Energy, CRISPR Therapeutics, CSX, Editas, Mallinckrodt, Microsoft, Sun Life, Ultragenyx and More

Mallinckrodt PLC (NYSE: MNK) was maintained as Neutral but the price target was slashed to $21 from $37 (versus a $15.95 close) at B Riley/FBR. The consensus target price was $30.63.

Merus N.V. (NASDAQ: MRUS) was reiterated as Outperform with a $34 price target (versus a $13.73 close) at Wedbush Securities. The firm is looking for a data-rich second half of 2019 with catalysts coming from metastatic breast cancer.

Microsoft Corp. (NASDAQ: MSFT) was reiterated as Buy with a $125 price target at Credit Suisse in a year-end review of overseas views on international price increases. Microsoft closed down 0.8% at $100.39 on Friday, and it has a consensus target price of $125.39.

STAG Industrial Inc. (NYSE: STAG) was reiterated as Market Outperform with a $31 price target at JMP Securities. Shares closed at $24.67 on Friday, and they have a $29.58 consensus price target.

Sun Life Financial Inc. (NYSE: SLF) was raised to Buy from Hold with a $39 target at Argus, versus a $32.58 prior close. The firm noted that its price target still implies a discounted forward earnings multiple versus successful peers and that its shares have been punished alongside financials while it has made several small acquisitions that should help to boost earnings per share.

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) was reiterated as Buy at SunTrust Robinson Humphrey, with a prior closing price of $41.87 and a consensus analyst target of $70.53.

Allianz’s chief economic adviser, Mohamed El-Erian, gave an interview with Fox News on Sunday, saying that he does not see a U.S. recession in 2019 but thinks that the volatility will allow for more of the 1,000-point swings in the Dow.

As a reminder, you don’t have to lose your shirt just because you see major drops in the stock market. Here are 10 exchange-traded funds that can help you avoid and even profit from a major stock market crash.

RBC Capital Markets has spoken favorably on gold for 2019 with global economic jitters remaining. The firm noted that gold could face a meaningful rally, as had been seen in 2016, and it sees a return to $1,300 per ounce in early 2019, up from $1,285 currently. Its silver assumptions remain at $16.50 per ounce (versus about $15.50 currently), but RBC noted that it would likely trade in line with gold.

Friday’s top analyst upgrades and downgrades included Adobe, Dell, Diamondback Energy, Lending Tree, Oxford Industries, Philip Morris, Wingstop and many more. Thursday’s top analyst upgrades and downgrades included Altbaba, Autodesk, AutoZone, CBS, Eli Lilly, Lululemon Athletica, Michaels, Target and more.